Form 8-K - Current report:
SEC Accession No. 0000950170-25-104969
Filing Date
2025-08-07
Accepted
2025-08-07 16:03:13
Documents
12
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20250807.htm   iXBRL 8-K 46677
2 EX-99.1 acet-ex99_1.htm EX-99.1 164920
3 GRAPHIC img94724212_0.jpg GRAPHIC 5549
  Complete submission text file 0000950170-25-104969.txt   336705

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20250807.xsd EX-101.SCH 25038
15 EXTRACTED XBRL INSTANCE DOCUMENT acet-20250807_htm.xml XML 4753
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 251193802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)